XP19986

· XenoPort, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XP19986, covering 2021-02-21 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury [Phase 2]